What does Alar Pharmaceuticals Inc. do?

Alar Pharmaceuticals Inc. (6785.TWO) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6785.TWO's market cap?

Alar Pharmaceuticals Inc. (6785.TWO) has a market capitalization of approximately $6.63 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 6785.TWO pay a dividend?

Yes — Alar Pharmaceuticals Inc. (6785.TWO) pays a dividend annually, with a trailing-twelve-month yield of 0.10%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

Is 6785.TWO profitable?

Alar Pharmaceuticals Inc. (6785.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6785.TWO

Alar Pharmaceuticals Inc.

TWO·Medical, Pharmaceuticals · Healthcare

NT$99.30NT$3.60+3.76%

Market capNT$6.63B·Aug 26 5:30 AM UTC

Price Chart

NT$99.30+NT$3.60 (+3.76%)today

+99.80%CAGR +14.85%

Select date range

FromTo

Oct 5, 2020Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.10%

Annual Dividend (FWD)NT$0.10

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent DividendNT$0.100

Ex-Dividend DateAug 25

Payment DateSep 14

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateNov 5

Last Report DateAug 6

Reported vs EstimateNT$0.23

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$3.00M

Net Income−NT$72.13M

Net Margin−2,404.3%

Operating Cash Flow−NT$154.91M

Capital ExpendituresNT$2.98M

Free Cash Flow−NT$157.88M

Return on Equity−3.0%

Return on Invested Capital0.2%

Net CashNT$2.28B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6785.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6785.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6785.TWO and 80,000+ other tickers.

About Alar Pharmaceuticals Inc.

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.

CEO: Yung Shun Wen
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: TWO
Employees: 32
Website: alarpharm.com

Peers

Handa Pharmaceuticals, Inc.

Cap

NT$12.6B

4114.TWO

Synmosa Biopharma Corporation

Cap

NT$16.1B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6785.TWO

What does Alar Pharmaceuticals Inc. do?: Alar Pharmaceuticals Inc. (6785.TWO) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6785.TWO's market cap?: Alar Pharmaceuticals Inc. (6785.TWO) has a market capitalization of approximately $6.63 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 6785.TWO pay a dividend?: Yes — Alar Pharmaceuticals Inc. (6785.TWO) pays a dividend annually, with a trailing-twelve-month yield of 0.10%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.
Is 6785.TWO profitable?: Alar Pharmaceuticals Inc. (6785.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.